Literature DB >> 22339596

Y-box-binding protein 1 (YB-1) and its functions.

I A Eliseeva1, E R Kim, S G Guryanov, L P Ovchinnikov, D N Lyabin.   

Abstract

This review describes the structure and functions of Y-box binding protein 1 (YB-1) and its homologs. Interactions of YB-1 with DNA, mRNAs, and proteins are considered. Data on the participation of YB-1 in DNA reparation and transcription, mRNA splicing and translation are systematized. Results on interactions of YB-1 with cytoskeleton components and its possible role in mRNA localization are discussed. Data on intracellular distribution of YB-1, its redistribution between the nucleus and the cytoplasm, and its secretion and extracellular functions are summarized. The effect of YB-1 on cell differentiation, its involvement in extra- and intracellular signaling pathways, and its role in early embryogenesis are described. The mechanisms of regulation of YB-1 expression in the cell are presented. Special attention is paid to the involvement of YB-1 in oncogenic cell transformation, multiple drug resistance, and dissemination of tumors. Both the oncogenic and antioncogenic activities of YB-1 are reviewed. The potential use of YB-1 in diagnostics and therapy as an early cancer marker and a molecular target is discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22339596     DOI: 10.1134/S0006297911130049

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  139 in total

1.  Overexpression of YB1 and EZH2 are associated with cancer metastasis and poor prognosis in renal cell carcinomas.

Authors:  Yong Wang; Yajing Chen; Hua Geng; Can Qi; Yunde Liu; Dan Yue
Journal:  Tumour Biol       Date:  2015-04-17

2.  The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy.

Authors:  Suhu Liu; Anna E Marneth; Gabriela Alexe; Sarah R Walker; Helen I Gandler; Darwin Q Ye; Katherine Labella; Radhika Mathur; Patricia A Toniolo; Michelle Tillgren; Prafulla C Gokhale; David Barbie; Ann Mullally; Kimberly Stegmaier; David A Frank
Journal:  Blood Adv       Date:  2018-12-11

3.  Anti-brain antibodies are associated with more severe cognitive and behavioral profiles in Italian children with Autism Spectrum Disorder.

Authors:  I S Piras; L Haapanen; V Napolioni; R Sacco; J Van de Water; A M Persico
Journal:  Brain Behav Immun       Date:  2014-01-03       Impact factor: 7.217

4.  Prognostic role of YB-1 expression in breast cancer: a meta-analysis.

Authors:  Xu Wang; Xiao-Bo Guo; Xiao-Chun Shen; Hao Zhou; Dan-Wei Wan; Xiao-Feng Xue; Ye Han; Bin Yuan; Jin Zhou; Hong Zhao; Qiao-Ming Zhi; Yu-Ting Kuang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

5.  A novel recombinant papillomavirus genome enabling in vivo RNA interference reveals that YB-1, which interacts with the viral regulatory protein E2, is required for CRPV-induced tumor formation in vivo.

Authors:  Natalie Leiprecht; Ekaterina Notz; Johanna Schuetz; Juliane Haedicke; Frank Stubenrauch; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2014-05-26       Impact factor: 6.166

Review 6.  The structure, function and evolution of proteins that bind DNA and RNA.

Authors:  William H Hudson; Eric A Ortlund
Journal:  Nat Rev Mol Cell Biol       Date:  2014-10-01       Impact factor: 94.444

Review 7.  Stress granules, P-bodies and cancer.

Authors:  Paul Anderson; Nancy Kedersha; Pavel Ivanov
Journal:  Biochim Biophys Acta       Date:  2014-12-05

8.  YB-1 functions as a porter to lead influenza virus ribonucleoprotein complexes to microtubules.

Authors:  Atsushi Kawaguchi; Ken Matsumoto; Kyosuke Nagata
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

9.  Expression of YB-1 enhances production of murine leukemia virus vectors by stabilizing genomic viral RNA.

Authors:  Wei Li; Xinlu Wang; Guangxia Gao
Journal:  Protein Cell       Date:  2012-12-08       Impact factor: 14.870

Review 10.  Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?

Authors:  D Dolfini; R Mantovani
Journal:  Cell Death Differ       Date:  2013-03-01       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.